Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | Director | August 12, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date August 12, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,405 |
Reported balance
After 2026-08-12 transaction · row 1
1 source rowRow 1 · 2026-08-12 · Grant · Acquired 472 · Balance 17,405 F1: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2026 Filed Aug 14, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 472 | $26.50 | $12,508.00 |
DisclosureSEC source: 0001193125-26-352528 · ownership.xml · nonDerivative · entry 1 Newman Kurt Douglas · CIK 0002074784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,405 F1 · kind: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:37 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 7,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-217219 · ownership.xml · nonDerivative · entry 1 Newman Kurt Douglas · CIK 0002074784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,933 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 9,737 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-103196 · ownership.xml · nonDerivative · entry 1 Newman Kurt Douglas · CIK 0002074784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,737 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 8, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.